Vol.

No.

October 02, 2020Oct 02, 2020

Free

DOWNLOAD THE PDF

Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds

Cover Story

Free

Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds

By Alexandria Carolan, Katie Goldberg and Matthew Bin Han Ong

Women in oncology who face gender bias know what not to do: seek help from their institutions.

Free

In their own words: Responses to The Cancer Letter survey on gender bias

Conversation with The Cancer Letter Free

Pamela Kunz: “In any other industry, if someone had behavior like that, they would be fired.”

By Alexandria Carolan

Conversation with The Cancer Letter Free

Leonidas Platanias: These incidents are “really shocking and disturbing”

By Alexandria Carolan

Clinical Free Trials & Tribulations

The cancer detection rate—a public health approach to early detection

By Joshua J. Ofman and Azra Raza

In Brief

C. Kent Osborne steps down as director of Dan L Duncan Comprehensive Cancer Center

Ruben Mesa named executive director of the Mays Cancer Center

Stephen Gruber named head of City of Hope's Center for Precision Medicine

Deirdre Cohen named director of Mount Sinai's Gastrointestinal Oncology Program

James B. Yu named associate chief medical officer for radiation oncology at Smilow

Yale awarded SPORE for head and neck cancer research

VICC receives “exceptional” score with renewal as an NCI-designated Comprehensive Cancer Center

AACR convenes conference on health disparities

Melanoma researchers at UCLA receive $13M grant from NIH

Ohio State receives $10M NCI grant to study impact of COVID-19 in first responders

Ohio State receives $9.1M NCI Grant renewal to support cancer retrovirus research

Cancer genomic screening program LC-SCRUM-Asia adopts latest Thermo Fisher Scientific NGS solutions

ACS CAN: Executive order on pre-existing condition protections unlikely to help cancer patients and survivors

Funding Opportunities

Lymphoma Research Foundation announces $10M initiative for follicular lymphoma clinical research

The Mark Foundation for Cancer Research launches drug discovery partnerships

Clinical Roundup

Corticosteroids improve survival in critically ill COVID-19 patients

Phase III trial shows Opdivo significantly improves DFS as adjuvant therapy for muscle-invasive urothelial carcinoma

Yale study reinforces benefit of using targeted therapy for early-stage NSCLC

Drugs & Targets

Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma

Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC

University of Illinois scientists enter licensing deal with Bayer, Systems Oncology

Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors

NCI Trials

NCI Trials for Oct. 2020

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 35 - September 26, 2025

Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds

In their own words: Responses to The Cancer Letter survey on gender bias

Pamela Kunz: “In any other industry, if someone had behavior like that, they would be fired.”

Leonidas Platanias: These incidents are “really shocking and disturbing”

The cancer detection rate—a public health approach to early detection

In Brief

C. Kent Osborne steps down as director of Dan L Duncan Comprehensive Cancer Center

Ruben Mesa named executive director of the Mays Cancer Center

Stephen Gruber named head of City of Hope's Center for Precision Medicine

Deirdre Cohen named director of Mount Sinai's Gastrointestinal Oncology Program

James B. Yu named associate chief medical officer for radiation oncology at Smilow

Yale awarded SPORE for head and neck cancer research

VICC receives “exceptional” score with renewal as an NCI-designated Comprehensive Cancer Center

AACR convenes conference on health disparities

Melanoma researchers at UCLA receive $13M grant from NIH

Ohio State receives $10M NCI grant to study impact of COVID-19 in first responders

Ohio State receives $9.1M NCI Grant renewal to support cancer retrovirus research

Cancer genomic screening program LC-SCRUM-Asia adopts latest Thermo Fisher Scientific NGS solutions

ACS CAN: Executive order on pre-existing condition protections unlikely to help cancer patients and survivors

Funding Opportunities

Lymphoma Research Foundation announces $10M initiative for follicular lymphoma clinical research

The Mark Foundation for Cancer Research launches drug discovery partnerships

Clinical Roundup

Corticosteroids improve survival in critically ill COVID-19 patients

Phase III trial shows Opdivo significantly improves DFS as adjuvant therapy for muscle-invasive urothelial carcinoma

Yale study reinforces benefit of using targeted therapy for early-stage NSCLC

Drugs & Targets

Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma

Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC

University of Illinois scientists enter licensing deal with Bayer, Systems Oncology

Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors

NCI Trials

NCI Trials for Oct. 2020

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login